ST2 and prognosis in acutely decompensated heart failure: The international ST2 consensus panel

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 26B-31B

  Januzzi, James L ^a   Mebazaa, Alexandre ^b   Di Somma, Salvatore ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER; CYTOKINE RECEPTOR; INTERLEUKIN 33; INTERLEUKIN RECEPTOR; NATRIURETIC FACTOR; ST2 PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; IL1RL1 PROTEIN, HUMAN;

ACUTE HEART FAILURE; AGED; ARTICLE; CONCENTRATION (PARAMETERS); CONSENSUS; DEATH; HEART ARRHYTHMIA; HEART MUSCLE FIBROSIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PUMP; RISK ASSESSMENT; ACUTE DISEASE; BLOOD; HEART FAILURE;

ACUTE DISEASE; BIOLOGICAL MARKERS; CONSENSUS; HEART FAILURE; HUMANS; PROGNOSIS; RECEPTORS, CELL SURFACE;

EID: 84925014324     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.037     Document Type: Article

References (23)

1. D.T. Ko, J.V. Tu, F.A. Masoudi, Y. Wang, E.P. Havranek, S.S. Rathore, A.M. Newman, L.R. Donovan, D.S. Lee, J.M. Foody, and H.M. Krumholz Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada Arch Intern Med 165 2005 2486 2492
2. J.L. Januzzi Jr., and G.M. Felker Surfing the biomarker tsunami at JACC: heart failure JACC Heart Fail 1 2013 213 215
3. R.R. van Kimmenade, and J.L. Januzzi Jr. Emerging biomarkers in heart failure Clin Chem 58 2012 127 138
4. L. Daniels, and A. M Natriuretic peptides JACC 50 2007 2357 2368
5. F. Liang, and D.G. Gardner Mechanical strain activates BNP gene transcription through a p38/NF-κB-dependent mechanism J Clin Invest 101 1999 1603 1612
6. G. Fonarow, W. Peacock, C. Phillips, M. Givertz, and L. M Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure JACC 49 2007 1943 1950
7. A. Chen, M. Wood, D. Krauser, A. Baggish, R. Tung, S. Anwaruddin, M. Picard, and J. JL NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) echocardiographic substudy Eur Heart J 27 2006 839 845
8. C.W. Yancy, M. Jessup, B. Bozkurt, J. Butler, D.E. Casey Jr., M.H. Drazner, G.C. Fonarow, S.A. Geraci, T. Horwich, J.L. Januzzi, M.R. Johnson, E.K. Kasper, W.C. Levy, F.A. Masoudi, P.E. McBride, J.J. McMurray, J.E. Mitchell, P.N. Peterson, B. Riegel, F. Sam, L.W. Stevenson, W.H. Tang, E.J. Tsai, and B.L. Wilkoff 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
9. E.O. Weinberg, M. Shimpo, S. Hurwitz, S. Tominaga, J.L. Rouleau, and R.T. Lee Identification of serum soluble ST2 receptor as a novel heart failure biomarker Circulation 107 2003 721 726
10. E.O. Weinberg, M. Shimpo, G.W. De Keulenaer, C. MacGillivray, S. Tominaga, S.D. Solomon, J.L. Rouleau, and R.T. Lee Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction Circulation 106 2002 2961 2966
11. K. Seki, S. Sanada, A.Y. Kudinova, M.L. Steinhauser, V. Handa, J. Gannon, and R.T. Lee Interleukin-33 prevents apoptosis and improves survival after experimental myocardial infarction through ST2 signaling Circ Heart Fail 2 2009 684 691
12. J.L. Januzzi Jr., W.F. Peacock, A.S. Maisel, C.U. Chae, R.L. Jesse, A.L. Baggish, M. O'Donoghue, R. Sakhuja, A.A. Chen, R.R. van Kimmenade, K.B. Lewandrowski, D.M. Lloyd-Jones, and A.H. Wu Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study J Am Coll Cardiol 50 2007 607 613
13. T. Mueller, B. Dieplinger, A. Gegenhuber, W. Poelz, R. Pacher, and M. Haltmayer Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure Clin Chem S4 2008 752 756
14. S. Rehman, T. Mueller, and J. JL Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure JACC 52 2008 1458 1465
15. S. Manzano-Fernandez, T. Mueller, D. Pascual-Figal, Q.A. Truong, and J.L. Januzzi Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction Am J Cardiol 107 2011 259 267
16. R. Shah, A. Chen-Tournoux, M. Picard, R. van Kimmenade, and J.L. Januzzi Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea Circ Heart Fail 2 2009 311 319
17. B. Dieplinger, J.L. Januzzi Jr., M. Steinmair, C. Gabriel, W. Poelz, M. Haltmayer, and T. Mueller Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay Clin Chim Acta 409 2009 33 40
18. T. Mueller, and B. Dieplinger The Presage(®) ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2 Expert Rev Mol Diagn 13 2012 13 30
19. T. Mueller, M. Zimmermann, B. Dieplinger, H.J. Ankersmit, and M. Haltmayer Comparison of plasma concentrations of soluble ST2 measured by three different commercially available assays: the MBL ST2 assay, the Presage ST2 assay, and the R&D ST2 assay Clin Chim Acta 413 2012 1493 1494
20. J.L. Zilinski, R.V. Shah, H.K. Gaggin, M.L. Gantzer, T.J. Wang, and J.L. Januzzi Jr. Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy Crit Care 16 2012 R135
21. S. Manzano-Fernandez, J.L. Januzzi, F.J. Pastor-Perez, J.C. Bonaque-Gonzalez, M. Boronat-Garcia, D.A. Pascual-Figal, S. Montalban-Larrea, M. Navarro-Penalver, J.M. Andreu-Cayuelas, and M. Valdes Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure Cardiology 122 2012 158 166
22. J.L. Januzzi Jr., and R.R. van Kimmenade Importance of rigorous evaluation in comparative biomarker studies J Am Coll Cardiol 63 2013 167 169
23. J. Lassus, E. Gayat, C. Mueller, W.F. Peacock, J. Spinar, V.P. Harjola, R. van Kimmenade, A. Pathak, T. Mueller, S. Disomma, M. Metra, D. Pascual-Figal, S. Laribi, D. Logeart, S. Nouira, N. Sato, M. Potocki, J. Parenica, C. Collet, A. Cohen-Solal, J.L. Januzzi Jr., and A. Mebazaa Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study Int J Cardiol 168 2013 2186 2194